持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/12/07 | 3,370 | 3,445 | 3,345 | 3,445 | +110 | +3.3% | 48,700 |
| 2021/12/06 | 3,355 | 3,400 | 3,330 | 3,335 | +15 | +0.5% | 97,200 |
| 2021/12/03 | 3,230 | 3,320 | 3,230 | 3,320 | +100 | +3.1% | 36,500 |
| 2021/12/02 | 3,180 | 3,265 | 3,175 | 3,220 | +15 | +0.5% | 46,300 |
| 2021/12/01 | 3,165 | 3,225 | 3,155 | 3,205 | +25 | +0.8% | 37,700 |
| 2021/11/30 | 3,200 | 3,275 | 3,180 | 3,180 | -20 | -0.6% | 125,900 |
| 2021/11/29 | 3,240 | 3,240 | 3,190 | 3,200 | -100 | -3% | 77,700 |
| 2021/11/26 | 3,380 | 3,380 | 3,280 | 3,300 | -70 | -2.1% | 44,200 |
| 2021/11/25 | 3,355 | 3,380 | 3,345 | 3,370 | +20 | +0.6% | 26,100 |
| 2021/11/24 | 3,345 | 3,375 | 3,345 | 3,350 | -5 | -0.1% | 44,000 |
| 2021/11/22 | 3,345 | 3,370 | 3,330 | 3,355 | -20 | -0.6% | 30,300 |
| 2021/11/19 | 3,365 | 3,385 | 3,350 | 3,375 | +20 | +0.6% | 42,100 |
| 2021/11/18 | 3,365 | 3,370 | 3,320 | 3,355 | -40 | -1.2% | 37,300 |
| 2021/11/17 | 3,420 | 3,420 | 3,375 | 3,395 | -35 | -1% | 28,900 |
| 2021/11/16 | 3,460 | 3,480 | 3,415 | 3,430 | -35 | -1% | 35,900 |
| 2021/11/15 | 3,410 | 3,465 | 3,400 | 3,465 | +70 | +2.1% | 62,000 |
| 2021/11/12 | 3,340 | 3,400 | 3,340 | 3,395 | +60 | +1.8% | 56,500 |
| 2021/11/11 | 3,375 | 3,385 | 3,330 | 3,335 | -40 | -1.2% | 21,700 |
| 2021/11/10 | 3,395 | 3,400 | 3,360 | 3,375 | ±0 | ±0% | 25,500 |
| 2021/11/09 | 3,325 | 3,415 | 3,325 | 3,375 | +65 | +2% | 67,700 |
| 2021/11/08 | 3,435 | 3,505 | 3,300 | 3,310 | -115 | -3.4% | 128,000 |
| 2021/11/05 | 3,285 | 3,455 | 3,235 | 3,425 | +80 | +2.4% | 146,600 |
| 2021/11/04 | 3,390 | 3,395 | 3,335 | 3,345 | -10 | -0.3% | 60,800 |
| 2021/11/02 | 3,355 | 3,380 | 3,345 | 3,355 | -10 | -0.3% | 40,800 |
| 2021/11/01 | 3,320 | 3,375 | 3,315 | 3,365 | +55 | +1.7% | 41,500 |
| 2021/10/29 | 3,285 | 3,330 | 3,265 | 3,310 | +25 | +0.8% | 59,600 |
| 2021/10/28 | 3,290 | 3,295 | 3,230 | 3,285 | +5 | +0.2% | 273,800 |
| 2021/10/27 | 3,290 | 3,310 | 3,255 | 3,280 | +20 | +0.6% | 77,400 |
| 2021/10/26 | 3,245 | 3,265 | 3,225 | 3,260 | +50 | +1.6% | 71,800 |
| 2021/10/25 | 3,225 | 3,245 | 3,195 | 3,210 | -60 | -1.8% | 66,800 |
| 2021/10/22 | 3,245 | 3,300 | 3,245 | 3,270 | -5 | -0.2% | 42,400 |
| 2021/10/21 | 3,275 | 3,315 | 3,255 | 3,275 | -10 | -0.3% | 39,600 |
| 2021/10/20 | 3,295 | 3,300 | 3,260 | 3,285 | +30 | +0.9% | 41,600 |
| 2021/10/19 | 3,230 | 3,265 | 3,230 | 3,255 | +5 | +0.2% | 36,200 |
| 2021/10/18 | 3,295 | 3,295 | 3,240 | 3,250 | -55 | -1.7% | 41,400 |
| 2021/10/15 | 3,260 | 3,305 | 3,255 | 3,305 | +50 | +1.5% | 39,800 |
| 2021/10/14 | 3,220 | 3,260 | 3,210 | 3,255 | +5 | +0.2% | 40,600 |
| 2021/10/13 | 3,255 | 3,270 | 3,225 | 3,250 | +10 | +0.3% | 33,500 |
| 2021/10/12 | 3,310 | 3,310 | 3,240 | 3,240 | -85 | -2.6% | 45,000 |
| 2021/10/11 | 3,295 | 3,325 | 3,280 | 3,325 | +20 | +0.6% | 39,700 |
| 2021/10/08 | 3,250 | 3,330 | 3,230 | 3,305 | +55 | +1.7% | 58,900 |
| 2021/10/07 | 3,310 | 3,310 | 3,250 | 3,250 | -40 | -1.2% | 55,700 |
| 2021/10/06 | 3,310 | 3,360 | 3,280 | 3,290 | -20 | -0.6% | 88,400 |
| 2021/10/05 | 3,345 | 3,360 | 3,295 | 3,310 | -55 | -1.6% | 76,200 |
| 2021/10/04 | 3,405 | 3,405 | 3,350 | 3,365 | -15 | -0.4% | 54,000 |
| 2021/10/01 | 3,420 | 3,420 | 3,350 | 3,380 | -40 | -1.2% | 69,600 |
| 2021/09/30 | 3,410 | 3,460 | 3,395 | 3,420 | +20 | +0.6% | 52,300 |
| 2021/09/29 | 3,375 | 3,400 | 3,345 | 3,400 | -50 | -1.4% | 108,000 |
| 2021/09/28 | 3,480 | 3,500 | 3,425 | 3,450 | -25 | -0.7% | 111,100 |
| 2021/09/27 | 3,575 | 3,575 | 3,475 | 3,475 | -100 | -2.8% | 68,600 |
851～
900
件表示中 / 3710件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 299,300円 | +5.1% | -7.0% | 2.67% | 19.65倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 東和薬品 | 305,500円 | +7.9% | -3.3% | 2.62% | 8.50倍 | 0.88倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 217,500円 | +3.1% | -6.5% | 2.21% | 10.09倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 150,500円 | -2.4% | -52.3% | 3.79% | 18.01倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 90,800円 | +20.3% | - | 0.00% | 160.99倍 | 1.20倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
